Torcetrapib for animal and human pharmacokinetic studies: Applicability of chiral and achiral methodologies

Bioanalysis

Volumn 1, Issue 3, 2009, Pages 619-628

  Ramesh, Mullangi ^a   Trivedi, Ravi Kumar ^b   Srinivas, Nuggehally R ^c  

^a Jubilant Innovation   (India)

^b DR REDDY'S LABORATORIES LTD   (India)

^c Suramus Biopharm   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; HYPOCHOLESTEROLEMIC AGENT; QUINOLINE DERIVATIVE; TORCETRAPIB;

ANIMAL; BLOOD; DOG; DRUG ANTAGONISM; DRUG DEVELOPMENT; HAMSTER; HAPLORHINI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; MOUSE; PHARMACOKINETICS; RAT; REVIEW; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; DOGS; DRUG DISCOVERY; HAPLORHINI; HUMANS; MICE; PHARMACOKINETICS; QUINOLINES; RATS; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

EID: 78650660457     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.42     Document Type: Review

References (24)

1. van der Steeg WA, Kuivenhoven JA, Klerkx AH, Boekholdt SM, Hoving GK, Kastelein JJ. Role of CETP inhibitors in the treatment of dyslipidemia. Curr. Opin. Lipidol. 15(6), 631-636 (2004).
2. Kastelein JJ, van Leuven SI, Evans GW et al. Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis. Curr. Med. Res. Opin. 23(4) 885-894 (2007).
3. Howes LG, Kostner K. The withdrawal of torcetapib from drug development: implications for the future of drugs that alter HDL metabolism. Expert Opin. Investig. Drugs 16(10), 1509-1516 (2007).
4. Tanne JH. Pfzer stops clinical trials of heart drug. BMJ 333 (7581), 1237 (2006).
5. 1H nuclear magnetic resonance. Drug Metab. Dispos. 36(10), 2064-2079 (2008).
6. Dalvie P, Chen W, Zhang C et al. Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans. Drug Metab. Dispos. 36(11), 2185-2198 (2008).
7. Trivedi RK, Dubey PK, Mullangi R, Srinivas NR. Development and validation of an enantioselective HPLC-UV method using Chiralpak AD-H to quantify (+)-and (-)-torcetrapib enantiomers in hamster plasma-application to a pharmacokinetic study. J. Chromatogr. B 857(2), 224-230 (2007).
8. Trivedi RK, Layek B, Kumar TS et al. Chiral bioanalysis of torcetrapib enantiomers in hamster plasma by normal-phase liquid chromatography and detection by atmospheric pressure chemical ionization tandem mass spectrometry. J. Chromatogr. B, 860(2), 227-234 (2007).
9. Trivedi RK, Dubey PK, Mullangi R, Srinivas NR. Development and validation of a sensitive LC-MS/MS method with electrospray ionization using multiple ions for quantitation of torcetrapib in hamster and dog plasma. Biomed. Chromatogr. 22(3), 316-326 (2008).
10. Wsol V, Skalova L, Szotakova B. Chiral inversion of drugs: coincidence or principle? Curr. Drug Metab. 5(6), 517-533 (2004).
11. Mustafa SS, Trivedi R, Mamidi NV, Mullangi R, Srinivas NR. Development and validation of a chiral liquid chromatographic method, based on Chiralpak to quantify enantiomers of (+/-)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar (S(-)-DRF 2725) to its antipode in plasma. J. Chromatogr. B 809(1), 23-30 (2004).
12. Yee L, Wong SH, Skrinska VA. Chiral high-performance liquid chromatographic analysis of fuoxetine and norfuoxetine in rabbit plasma, urine, and vitreous humor using an acetylated beta-cyclodextrin column. J. Anal. Toxicol. 24(7), 651-655 (2000).
13. Tao X, Kadaba PK, Nnane IP. Chiral liquid chromatography resolution and stereoselective pharmacokinetic study of the enantiomers of a novel anticonvulsant, N-(4-chlorophenyl)-1-(4-pyridyl)ethylamine, in rats. J. Chromatogr. B 796(1), 35-44 (2003).
14. Hefnaway MM, Sultan MA, Al-Shehri MM. HPLC separation technique for analysis of bufuralol enantiomers in plasma and pharmaceutical formulations using a vancomycin chiral stationary phase and UV detection. J. Chromatogr. B, 856(1-2), 328-336 (2007).
15. Hefnaway MM, Sultan MA, Al-Shehri MM. Enantioanalysis of bisoprolol in human plasma with a macrocyclic antibiotic HPLC chiral column using fuorescence detection and solid phase extraction. Chem. Pharm. Bull. 52(2), 227-230 (2007).
16. Link B, Haschke M, Wenk M, Krahenbuhl S. Determination of midazolam and its hydroxymetabolites in human plasma and oral fuid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21(9), 1531-1540 (2007).
17. Bhatt J, Subbaiah G, Kambli S et al. A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasma. J. Chromatogr. B 852(1-2), 115-121 (2007).
18. Nitin M, Rajanikanth M, Lal J, Madhusudanan K P, Gupta RC. Liquid chromatography-tandem mass spectrometric assay with a novel method of quantitation for the simultaneous determination of bulaquine and its metabolite, primaquine, in monkey plasma. J. Chromatogr. B, 793(2), 253-263 (2003).
19. Srinivas NR. Dodging matrix effects in liquid chromatography tandem mass spectrometric assays-compilation of key learnings and perspectives. Biomed. Chromatogr. 23(5), 451-454 (2009).
20. Layek B, Kumar TS, Trivedi RK, Mullangi R, Srinivas NR. Development and validation of a sensitive LC-MS/MS method with electrospray ionization for quantitation of rhein in human plasma: application to a pharmacokinetic study. Biomed. Chromatogr. 22(6), 616-624 (2008).
21. Umezawa H, Lee XP, Arima Y et al. Simultaneous determination of b-blockers in human plasma using liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 22(7), 702-711 (2008).
22. Krishna R, Anderson MS, Bergman AJ et al. Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals; two double-blind, randomised placebo-controlled studies. Lancet 370, 1907-1924 (2007).
23. Krishna R, Bergman AJ, Jin B et al. Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. Clin. Pharmacol. Ther. 84(6), 679-683 (2009).
24. Srinivas NR. New thinking in the development of novel derivatization reagents for liquid chromatography-mass spectrometric detection. Biomed. Chromatogr. 23(1), 107-108 (2009).